The 29 portfolio companies we’ve helped build have attracted more than $2.3B of risk capital, employ close to 1,000 Canadians and have a combined value of $4B.
Discover our portfolio companies below.
Website www.jenthera.com
Email laurent.ziri@jenthera.com
LinkedIn Visit our page
Line of business Therapeutics - Gene Editing
Jenthera Therapeutics is offers a new CRISPR technology by directly addressing the inherent limitations of current CRISPR methodologies.